122086 -

Evidence under reference 122086 illustrates the severe consequences when medication regimes—particularly for long-term metabolic or neurological conditions—are disrupted. A key issue identified is the between different brands of the same drug.

: Improving the "digital prescription" process so all parties—GP, consultant, and pharmacist—are synchronized. 122086

: For conditions like Parkinson's, the timing of medication is vital. Variations in how "controlled release" (CR) versions of drugs (e.g., Sinemet CR) are handled by pharmacies or communicated by GPs can lead to unsettling and time-consuming complications for the patient. Communication Gaps in Healthcare 122086